PP
THRN

PDT Partners’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

PDT Partners’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,585
Closed -$67K – 1206
2022
Q1 		$67K Buy
+10,585
New +$57K 0.01% 891

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's THRN Position: Q2 2022 in Review

PDT Partners sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q2 2022, closing a stake of 10,585 shares — an estimated $67K sold.

PDT Partners first reported a position in THRN in Q1 2022 and held it in 1 quarter. The position peaked at $67K in Q1 2022. 49 funds tracked by Wall St. Rank hold THRN as of Q2 2022.

  • PDT Partners reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • PDT Partners sold 10,585 Thorne Healthtech, Inc. Common Stock shares in Q2 2022, an estimated $67K.
  • PDT Partners first reported a position in Thorne Healthtech, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • PDT Partners's Thorne Healthtech, Inc. Common Stock position peaked at $67K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.